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Abstract
Background: Mantle cell lymphoma is a lymphoid entity characterized by adenopathy, blood and bone marrow
involment which only recurrent mucosal localisation is the lymphomatoid polyposis. Few other mucosal infiltrations
have been already reported.
Results: We report here the first case of a unique tracheal localisation of mantle cell lymphoma at presentation of
the disease. The presence of classical t(11;14)(q13;q32) confirmed the diagnosis of mantle cell lymphoma by
eliminating MALT or cancer localisation.
Conclusion: This case illustrates the necessity to ensure the diagnosis of mucosal lymphoma versus MCL since
these diseases need different treatment regimens and prognoses.
To the Editor,
We report here an unusual case of a tracheal localisa-
tion of mantle cell lymphoma (MCL). The patient was
75-years-old and hospitalized for dyspnoea, dysphonia
and stridor, evolving from 3 months. No superficial
tumoural syndrome was observed and the patient did
not express B-symptoms. The CT-scan showed the pre-
sence of an endotracheal tumour of two centimetres
under the glottis and two mediastinal centimetric lymph
nodes. No other localisations were found. The bronchial
endoscopy showed an obstructive vascularised tumour
(Figure 1), and the stomach endoscopy was negative.
The pneumologist took multiple biopsies and used both
laser and endotracheal prothesis to treat the dyspnoea.
The anatomo-pathologist identified a massive prolifera-
tion of medium to large cells with abundant and clear
cytoplasm, round or oval nuclei. Mitosis were observed.
Those cells were CD20+/bcl-2+ lymphoid cells with no
lymphoepithelial lesions. Cells expressed the CD5+.
Many lymphoid cells expressed Cyclin D1 (Monoclonal
anti-mouse, clone SP4, Lab Vision). Some CD23+ den-
dritic cells were observed. CD138 and ALC stains were
negative, excluding plasmacytoma and solid tumour.
Fluorescence in situ hybridisation of tracheal tumour
revealed the presence of a t(11;14)(q13;q32) transloca-
tion. We made the diagnosis of MCL. Furthermore,
blood and bone marrow exams did not show any abnor-
mal lymphoid B cells with cytological and molecular
exams. The patient was treated with four courses of
Vincristine-Adriamycin-Dexamethasone-Chloramino-
phene followed by four injections of Rituximab. We
obtained a complete haematological, cytogenetical and
isotopic remission. The patient is still alive and in com-
plete remission, 4 years after the diagnosis.
Mantle cell lymphoma is a lymphoid entity defined by
clinical, cytological, immunological, biochemical and
cytogenetic criteria [1]. One particular entity of MCL,
lymphomatoid polyposis, is characterised by the involve-
ment of the gastrointestinal tract (30%), distinct from a
mucosal associated lymphoid tissue (MALT) localisation
[2,3]. The frequency of MALT in the trachea is very
low; however, nasopharynx and Waldeyer’s ring localisa-
tions of MCL mimicking MALT have been reported
[4,5]. Dyspnoea was previously described in mediastinal
involvement of MCL compressing the trachea [6]. Two
cases have been already reported but there were relapse
site or one of the multiple localisation of the MCL [7,8].
This case is different because of its unique localisation
and the fact that it is the first evolution of the disease.
Because tracheal involment is most seen in cancer and
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it is important to maximise the chance of an accurate
diagnosis by correlating anatomo-pathologist and cyto-
genetic exams so as not to underestimate the incidence
of atypical MCL in cancer/MALT localisation. This case
illustrates the necessity to ensure the diagnosis of muco-
sal lymphoma versus MCL since these diseases have dif-
ferent treatment regimens and prognoses.
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Figure 1 The sagittal CT-scan showed the presence of an endotracheal tumour under the glottis (left panel). Presence of a vascularised
tumor of the trachea visible by bronchial endoscopy (right panel).
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